TY  - RPRT
TI  - Combined in silico docking and in vitro antiviral testing for drug repurposing identified lurasidone and elbasvir as SARS-CoV-2 and HCoV-OC43 inhibitors
AU  - Milani, M.
AU  - Donalisio, M.
AU  - Bonotto, R. M.
AU  - Schneider, E.
AU  - Arduino, I.
AU  - Boni, F.
AU  - Lembo, D.
AU  - Marcello, A.
AU  - Mastrangelo, E.
PY  - 2020
DO  - 10.1101/2020.11.12.379958
UR  - https://www.biorxiv.org/content/10.1101/2020.11.12.379958v1
ID  - 10.1101/2020.11.12.379958
ER  -